- AllStripes, a San Francisco-based healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced it has raised $50 million in Series B funding led by Lux Capital, a current investor, joined by JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, and Maveron. The round also included participation from angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
UPMC Launches Drug Discovery Company Novasenta to Develop Targeted Immunotherapy Drugs for Cancer
What You Should Know:
- UPMC today announced the launch of Novasenta, a drug discovery and development company seeking novel and effective treatments for cancer. Co-founded in late 2018 by Robert Ferris, M.D., Ph.D., Dario Vignali, Ph.D., and Greg Delgoffe, Ph.D., all of the UPMC Hillman Cancer Center and Pitt, Novasenta is currently focused on T-cell targets and rapidly advancing programs with the goal of launching its first clinical trial by the end of 2023.
- Based on years
Read More
5-Step Guide to Hiring AI Talent for Digital Health, Biotech & Life Sciences Companies
Artificial Intelligence (AI) will disrupt healthcare's destiny for good. Here are five steps digital health startups can take to find the premier talent to get the job done.
Not too long ago, AI was the topic of futuristic movies. What was once a fictional draw at the Box Office is now a reality in offices worldwide. AI is everywhere and rapidly transforming the way we work. What remains scarce though is the technical talent in healthcare to see this tech revolution through.
AI
Read More
Verily Acquires Clinical Trials Management Platform SignalPath, Marks First Acquisition
What You Should Know:
Verily, an Alphabet company announced an agreement to acquire SignalPath, a Raleigh, NC-based clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. Financial details of the acquisition were not disclosed.
- The acquisition marks Verily’s first major acquisition that will strengthen and expand Verily’s existing clinical trial system and evidence generation platform, known as Baseline. The
Read More
Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials
What You Should Know:
- Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. This latest funding brings the company’s valuation to $2.2B.
- Reify Health has built a new foundation for how clinical trials are run through its
Read More
Colgate Taps Verily’s Baseline Platform for Oral Health Research
What You Should Know:
- Verily and Colgate, today announce a new oral health study as part of Verily’s ongoing Baseline Health Study that will aim to improve understanding of the connections between oral health and overall human health. The study will assess how oral health practices affect health more broadly.
- The study’s goal is to see how oral health practices, including intensive non-surgical periodontal therapy, as well as a robust Colgate home oral hygiene regimen monitored through
Read More
Cardinal Health Leverages Blockchain to Streamline Pharmaceutical Supply Chain
What You Should Know:
- Cardinal Health and Chronicled announced a partnership to leverage a new blockchain-powered solution on the MediLedger Network to streamline operations across the pharmaceutical supply chain and enable a reliable, frictionless experience for pharmacies across the country. The new blockchain solution will allow Cardinal Health to optimize the complex process of pharmaceutical chargebacks and create greater connectivity for its suppliers and
Read More
ARTIS Ventures Announces 2021 Class of Healthcare and Life Sciences Fellows
What You Should Know:
- ARTIS Ventures (“AV”), a venture firm focused on pioneering investments in biotech, health, and life sciences, today announced the candidates chosen for the AV Fellows program. The year-long program includes a diverse group of nine fellows from across the world, chosen from more than 150 applicants currently enrolled in a Ph.D. or MD program (or postdoc/residency) with technical expertise ranging from computational biology, synthetic biology, microbiome engineering,
Read More
Syneos Health, Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
What You Should Know:
- Aetion, a leader in real-world evidence analysis, and Syneos Health® (Nasdaq:SYNH), one of the largest CROs, announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes.
- The partnership aims to generate meaningful real-world evidence (RWE) across all phases of the product lifecycle – introducing commercial expertise and insights far earlier in the clinical process – to
Read More
How Logmore’s Condition Monitoring System Is Securing COVID-19 Vaccine Distribution
With the COVID-19 vaccination rollout in high gear, innovative data technologies are critical to the success of the most ambitious inoculation effort in human history.
There are many challenges involved with trying to vaccinate so many people in such a short amount of time. It hasn’t helped that the leading vaccines require extra cold temperatures in order to remain effective. The “cold chain” is a significant challenge even in the most developed countries in the world. In the US, safe
Read More
